Howard to replace Lefevre in 3rd "Twilight" film

Cast member Bryce Dallas Howard poses at the U.S. premiere of the film ''Terminator Salvation'' at the Grauman's Chinese theatre in Hollywood, California, May 14, 2009. REUTERS/Danny Moloshok

Cast member Bryce Dallas Howard poses at the U.S. premiere of the film ''Terminator Salvation'' at the Grauman's Chinese theatre in Hollywood, California, May 14, 2009.

Credit: Reuters/Danny Moloshok

Wed Jul 29, 2009 6:40pm EDT

LOS ANGELES (Hollywood Reporter) - "Eclipse" is pulling a switcheroo.

In the third installment of Summit's "Twilight" franchise, Rachelle Lefevre, who was to play the role of villain Victoria, will be replaced by Bryce Dallas Howard when shooting begins in Vancouver on August 17.

Lefevre played the role in the first picture, "Twilight," and in the upcoming "New Moon."

The studio attributed the move to scheduling conflicts. Lefevre recently was cast in the indie drama "Barney's Version" opposite Dustin Hoffman, which also has an August 17 start date, only several thousand kilometers east, in Quebec.

Dallas Howard has starred in "Terminator Salvation" and Spider-Man 3" as well as "Lady in the Water" and Lars von Trier's "Manderlay."

(Editing by Sheri Linden at Reuters)

Entertainment News From the Wrap

Photo

Newsweek Avoids Condoms, Nudity in ‘Politics of Sex’ Cover 12:41pm EST

Newsweek shows readers what cover was passed over, and in this case it was condoms, naked women and a vibrator

Photo

'Simpsons' Fans Break Guinness Record in Honor of Show's 500th Episode 11:52am EST

A pair of California fans watched 86 hours and 37 minutes -- consecutively -- worth of "Simpsons" episodes

Photo

'The Voice' Carries for Another NBC Monday Win 12:36pm EST

NBC's gamble continues to pay off as it tops once-bulletproof CBS sitcoms

Photo

Bill O'Reilly: Whitney Houston An 'Addict,' 'Wanted to Kill Herself' (Video) 11:22am EST

Fox News' prime time star took the occasion of Whitney Houston's passing to argue against drug legalization

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.